Award

(NU/1433 - 7) Sundara Pharmaceuticals Limited - The Provision of Business Consultancy to Assist Commercialisation of University Research. (2)

NEWCASTLE UNIVERSITY

This public procurement record has 1 release in its history.

Award

30 Jan 2020 at 10:31

Award Notice
Summary of the contracting process

The latest procurement process involves Newcastle University seeking business consultancy to assist in the commercialisation of university research, specifically related to the provision of consultancy services for Sundara Pharmaceuticals Limited. This initiative falls under the business and management consultancy industry category and is located in the North East of the United Kingdom. Currently, the procurement stage is complete, having concluded with an award date of January 30, 2020, and the contract is set to commence on February 3, 2020, and last until February 2, 2021. The total contract value is £30,000 and was awarded following a selective procurement method under a restricted procedure.

This tender presents significant opportunities for small and medium-sized enterprises (SMEs) that specialise in business consultancy, particularly those with expertise in pharmaceutical research and development. Companies that can demonstrate experience in guiding organisations through pre-clinical trials, regulatory approvals, and product market entry strategies would be particularly well-suited to compete. The connection with Newcastle University also opens avenues for collaborative projects and access to research resources, making this a potentially lucrative engagement for forward-thinking consulting firms.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

(NU/1433 - 7) Sundara Pharmaceuticals Limited - The Provision of Business Consultancy to Assist Commercialisation of University Research. (2)

Notice Description

A Professor in Pharmaceutical Chemistry, Roz Anderson joined the University in 1987 and in her 31 year career as a researcher worked on the treatment of Alzheimer's disease, diagnosis of bacterial infections, psoriasis and cancer, but her particular passion was the battle against the rare genetic disorder "Cystinosis". For the last 20 years of her life Roz undertook research to find a better, more efficiently targeted method of delivering cysteamine - which is a toxic and noxious drug used in the management of the rare life limiting genetic disorder Cystinosis. The pre-clinical development of CF10 will provide a GMP-compliant synthetic route, GLP toxicology, toxicokinetic and safety data, and a clinical trial proposal. The results will support a 1st in human CF10 clinical trial. Early pre-clinical trials suggest that the bio-availability of cysteamine delivered by CF10 is twice that achieved by current treatment. This improvement, together with its more efficient mode of delivery, allows for a significant reduction in both the required dose and the frequency of dose, thereby leading to an anticipated reduction in side effects and better adherence to the medication regime. The University established the spin-out company, ''Sundara Pharmaceuticals'', which has been formed with the brief "to enhance the research before undertaking pre-clinical trials, obtaining regulatory approval and either bringing CF10 to market itself or selling to a larger pharma business." The formation of ''Sundara Pharmaceuticals'' facilitated a PS1.56m Medical Research Grant award to undertake preclinical development that will take the drug to prodrug clinical trials, the award runs for a period of 24 months and the project commenced October2018. Sundara would now like to bring in a CEO to support the growth and development of the organisation.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/1b15eca4-ad45-4455-862b-9159650eed99
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Works
Procurement Method
Selective
Procurement Method Details
Restricted procedure
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79400000 - Business and management consultancy and related services

Notice Value(s)

Tender Value
£30,000 Under £100K
Lots Value
Not specified
Awards Value
£30,000 Under £100K
Contracts Value
Not specified

Notice Dates

Publication Date
30 Jan 20206 years ago
Submission Deadline
12 Dec 2019Expired
Future Notice Date
Not specified
Award Date
30 Jan 20206 years ago
Contract Period
3 Feb 2020 - 2 Feb 2021 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NEWCASTLE UNIVERSITY
Contact Name
Natalie Morton
Contact Email
natalie.morton@ncl.ac.uk
Contact Phone
+44 1912086396

Buyer Location

Locality
NEWCASTLE
Postcode
NE1 7RU
Post Town
Newcastle upon Tyne
Country
England
Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC4 Northumberland, Durham and Tyne & Wear
Small Region (ITL 3)
TLC43 Tyneside
Delivery Location
TLC North East (England)
Local Authority
Newcastle upon Tyne
Electoral Ward
Monument
Westminster Constituency
Newcastle upon Tyne Central and West

Supplier Information

Number of Suppliers
1
Supplier Name

SAMER TASLAQ

Further Information

Notice Documents

Notice URLs

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f-2020-01-30T10:31:21Z",
    "date": "2020-01-30T10:31:21Z",
    "ocid": "ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "NCL001-DN448954-52644509",
        "title": "(NU/1433 - 7) Sundara Pharmaceuticals Limited - The Provision of Business Consultancy to Assist Commercialisation of University Research. (2)",
        "description": "A Professor in Pharmaceutical Chemistry, Roz Anderson joined the University in 1987 and in her 31 year career as a researcher worked on the treatment of Alzheimer's disease, diagnosis of bacterial infections, psoriasis and cancer, but her particular passion was the battle against the rare genetic disorder \"Cystinosis\". For the last 20 years of her life Roz undertook research to find a better, more efficiently targeted method of delivering cysteamine - which is a toxic and noxious drug used in the management of the rare life limiting genetic disorder Cystinosis. The pre-clinical development of CF10 will provide a GMP-compliant synthetic route, GLP toxicology, toxicokinetic and safety data, and a clinical trial proposal. The results will support a 1st in human CF10 clinical trial. Early pre-clinical trials suggest that the bio-availability of cysteamine delivered by CF10 is twice that achieved by current treatment. This improvement, together with its more efficient mode of delivery, allows for a significant reduction in both the required dose and the frequency of dose, thereby leading to an anticipated reduction in side effects and better adherence to the medication regime. The University established the spin-out company, ''Sundara Pharmaceuticals'', which has been formed with the brief \"to enhance the research before undertaking pre-clinical trials, obtaining regulatory approval and either bringing CF10 to market itself or selling to a larger pharma business.\" The formation of ''Sundara Pharmaceuticals'' facilitated a PS1.56m Medical Research Grant award to undertake preclinical development that will take the drug to prodrug clinical trials, the award runs for a period of 24 months and the project commenced October2018. Sundara would now like to bring in a CEO to support the growth and development of the organisation.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "79400000",
            "description": "Business and management consultancy and related services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "North East",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 30000,
            "currency": "GBP"
        },
        "procurementMethod": "selective",
        "procurementMethodDetails": "Restricted procedure",
        "tenderPeriod": {
            "endDate": "2019-12-12T23:59:59Z"
        },
        "contractPeriod": {
            "startDate": "2020-02-03T00:00:00Z",
            "endDate": "2021-02-02T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "works"
    },
    "parties": [
        {
            "id": "GB-CFS-59869",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "streetAddress": "Newcastle University, Procurement Services, Kingsgate",
                "locality": "Newcastle",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Natalie Morton",
                "email": "natalie.morton@ncl.ac.uk",
                "telephone": "+44 1912086396"
            },
            "details": {
                "url": "https://www.ncl.ac.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-135829",
            "name": "Samer Taslaq",
            "identifier": {
                "legalName": "Samer Taslaq"
            },
            "address": {
                "streetAddress": "52 Bedford Square London Greater London WC1b 3DP"
            },
            "details": {
                "scale": "sme",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-59869",
        "name": "Newcastle University"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f-1",
            "status": "active",
            "date": "2020-01-30T00:00:00Z",
            "datePublished": "2020-01-30T10:31:21Z",
            "value": {
                "amount": 30000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-135829",
                    "name": "Samer Taslaq"
                }
            ],
            "contractPeriod": {
                "startDate": "2020-02-03T00:00:00Z",
                "endDate": "2021-02-02T23:59:59Z"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/1b15eca4-ad45-4455-862b-9159650eed99",
                    "datePublished": "2020-01-30T10:31:21Z",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}